• Profile
Close

Serum pro-inflammatory factors as predictors of persistent diabetic macular oedema with limited anatomic response to anti-VEGF: Association with intravitreal injection treatment profiles in real-world setting

Acta Ophthalmologica Nov 23, 2019

Brito P, et al. - Researchers conducted the study for investigating the role of serum levels of pro-inflammatory factors in the identification of persistent diabetic macular oedema (DME) cases with the limited anatomic response to anti-VEGF, as well as analyzing possible predictive connections between serum factors and intravitreal treatment profiles. DME cases have been treated with monthly bevacizumab. In total, 58 cases have been involved receiving a mean of 7.23 ± 1.55 IVI in 12 months, resulting in a significant improvement of visual acuity and central foveal thickness. According to findings, serum markers of microvascular damage (high-sensitivity C-reactive protein, homocysteine and creatinine) were linked to a higher frequency of IVI due to persistent DME, indicating a role for such biomarkers in the identification of limited responders to anti-VEGF monotherapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay